Sunday, July 03, 2022 2:16:48 PM
(I) The outstanding shares was a little bit higher: 397 vs 395 (+2) … I think / assume the increase was 100% insiders. (I assume a “votes for” by these shares.)
(II) The voting shares* increased to 185 (from 143; + 42 / +29% … +39 / +28% exc. insiders above) … however it was the 47% of the outstanding shares (397).
*Please note: “Broker Non- Votes” was entitled to vote on accounting firm only, as a “routine” proposal … without this agenda point this type of vote does not count as present. Abstentions and broker non-votes counted for determining the presence or absence of a quorum, but will not be counted for determining the number of votes cast on a given proposal.
(III) We “know”:
a) Sarrissa has: 24
b) Baker B has: 21
c) Votes increased by 42 (39 exc. insiders)
d) “Broker votes” increased by 20 (I think fair to assume these are all individuals)
e) Non-individuals, non-insiders increased by 19 (as it is less than what BB has, I assume that BB voted in 2021)
(IV) re-elect Mr. Karim Mikhail (lowest “votes for” among re-election) vs re-elect Mr. Patrick J. O’Sullivan (highest “votes for” among re-election)
For: 93 vs 109: -16 … 91 vs 109 (exc. the +2 belongs to insiders, see I.): -18
Against: 37 vs 29: +8
Abstentions: 55 vs 5: +50 (w/o Sarissa: 31 vs 5: +26)
Against + Abstentions: 92 vs 34: +58 (w/o Sarissa: 68 vs 34: +34)
Who could be behind the change? (Against + Abstentions; w/o Sarissa: 68 vs 34: +34)
(i) +20: “new” individuals (Fair to assume they did not vote “For” and as it less than Sarissa’s 24, fair to assume that Sarissa’s current shares voted in 2021)
(ii) +14: individuals and institutions who voted in 2021 (as it and the decrease of "For" are less than BB’s shares, fair to assume that – at least part, but more likely full – they voted “For”.)
For vs Against + Abstentions: 93 vs 92 … approved
(Just for the record “best” re-election: 95 vs 89)
Altogether, I am not sure Denner is “comfortable” enough with the outcome to initiate a special meeting (especially if the pps will be higher …).
(i) 39 / 28% increase in total votes (exc. insiders 2) … 212 million did not vote.
(ii) all re-election was approved (with a tight margin, but was approved counting “Abstentions” as “Against”) … meanwhile the pps is below $2.
We could see a (one) board membership for him w/o a special meeting ... or (but I am not sure we will know it) he could be an advisor for the Board. ... or everything will be the same.
Best,
G
ps.: vote about Compensation Plan was more favorable “for Denner” but that does not matter
(i) everybody “love” to vote against compensation
(ii) it was a non-binding advisory vote
Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM